A blog about Business & Finance, Health & Wellness, and News.
Real Name: Daniel Haszard Gender: male Date of Birth: May 21, 1957 Member Since: September 06, 2007 Last Signed In: August 21, 2008 Profile Views: 74 Blog Views: 4228 Eli Lilly Zyprexa RICO Lawsuit Eli Lilly reaping Zyprexa whirlwind Eli Lilly ZYPREXA STORM Eli Lilly ZYPREXA GREED Zyprexa ' Chemical Straitjacket' Use by Children Lilly ZYPREXA DIABETES LINK Lilly Makes Billions Off Zyprexa While Approved for Schizophrenia Only Eli Lilly STALLING ZYPREXA PAYOUTS Addictive Zyprexa Pushed by Eli Lilly Drug Reps Eli Lilly Zyprexa Patients Thinking Sales Shrinking September 07 October 07 November 07 December 07 January 08 February 08 March 08 April 08 May 08 June 08 July 08 August 08 September 08 October 08 www.zyprexa-victims.com 
RSS 2.0    |
|
|
Federal Court Rejects Lilly's Preemption Argument in Utah Zyprexa case
FYI 
On Sept. 4, a federal court in Utah ruled against Eli Lilly which sought to absolve itself of Zyprexa liability. The State of Utah sued Eli Lily alleging that the State had paid for inappropriate, unnecessary and unauthorized off-label use of Zyprexa, and that it was entitled to relief including the future costs of care for Medicaid recipients allegedly harmed by the drug. Lilly invoked FDA's Preemption Rule which claims sole jurisdiction over drug safety issues. This gift to the pharmaceutical industry was crafted by FDA's chief counsel, Daniel Troy, before he went back to a law firm representing pharmaceutical companies. In effect, FDA preemption would deny citizens the right to seek relief for preventable harm caused by manufacturers' failure to warn about serious adverse effects linked to their FDA-approved prescription drugs. The court rejected Lilly's effort to remove the case from state court jurisdiction underscoring the court's "presumption against preemption." In an almost conclusory fashion, the Utah district court cited the following precedents: 1. Supreme Court Justice Scalia’s bon mot in Alexander v. Sandoval, 532 U.S. 275, 291 (2001), that “[a]gencies may play the sorcerer's apprentice but not the sorcerer himself.” (In Sandoval, Scalia was referring to agencies’ power to create a federal cause of action; here, the same metaphor is applied to agencies’ power to preempt state law.) 2. An earlier district court opinion from Louisiana which rejected FDA's assertion of preemption: “To take such drastic action based solely on a preamble inserted at the eleventh hour and drafted by an agency without the express or implied authority to abolish such remedies is Draconian and unacceptable.” More www.ahrp.org and http://ahrp.blogspot.com
Daniel Haszard www.zyprexa-victims.com
Eli Lilly Invest in Zyprexa successor.
Patent protection for,Lilly's zyprexa cash cow expires in 2011 will this new drug be an improvement?
 Interesting comments at this discussion thread
" The new drug that Lilly is testing in very early stages works less effectively than Zyprexa, but has reportedly fewer (not "no side effects").
(1) the test is one-fifth the size of a statistically accurate study,
(2) is, at 4 weeks, too short term to see its effects on diabetes, cholesterol levels or, for that matter, heart problems (like Biaxin),
(3) is the first of its kind and has not been corroborated, and
(4) the initial test results that Lilly published about Zyprexa were just as rosy as this one."
* * * * *
From Lilly's own PR news wire:
"About LY2140023
LY2140023 is an investigational drug from Lilly, which is being developed as a new treatment option for schizophrenia.
Most currently approved antipsychotic medications work by affecting the neurotransmitters dopamine or serotonin. For LY2140023, the active substance, LY404039, is thought to work by reducing the presynaptic release of another neurotransmitter, glutamate, in brain regions where mGlu2/3 receptors are expressed.
Further studies are planned or are ongoing to learn more about the safety and effectiveness, including determining an optimal therapeutic dose for LY2140023."
Daniel Haszard www.zyprexa-victims.com
 Zyprexa Molecule
|